Sandra Jesus

1.0k total citations
27 papers, 775 citations indexed

About

Sandra Jesus is a scholar working on Pharmaceutical Science, Molecular Biology and Immunology. According to data from OpenAlex, Sandra Jesus has authored 27 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 10 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Sandra Jesus's work include Advanced Drug Delivery Systems (12 papers), RNA Interference and Gene Delivery (9 papers) and Nanoparticle-Based Drug Delivery (6 papers). Sandra Jesus is often cited by papers focused on Advanced Drug Delivery Systems (12 papers), RNA Interference and Gene Delivery (9 papers) and Nanoparticle-Based Drug Delivery (6 papers). Sandra Jesus collaborates with scholars based in Portugal, Switzerland and United States. Sandra Jesus's co-authors include Olga Borges, Edna Soares, Gerrit Borchard, Mélanie Schmutz, Claudia Som, Peter Wick, Dimitrios Andreadis, Dimitrios G. Fatouros, Christina Karavasili and Maria Teresa Cruz and has published in prestigious journals such as ACS Applied Materials & Interfaces, Methods in enzymology on CD-ROM/Methods in enzymology and International Journal of Pharmaceutics.

In The Last Decade

Sandra Jesus

25 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Jesus Portugal 16 269 264 246 132 124 27 775
Beini Sun China 9 155 0.6× 239 0.9× 261 1.1× 136 1.0× 101 0.8× 22 784
Mohammad A. Obeid Jordan 20 264 1.0× 339 1.3× 176 0.7× 107 0.8× 232 1.9× 51 979
Alanood S. Almurshedi Saudi Arabia 16 273 1.0× 297 1.1× 140 0.6× 60 0.5× 94 0.8× 42 805
Vajihe Akbari Iran 22 187 0.7× 585 2.2× 234 1.0× 80 0.6× 166 1.3× 66 1.3k
Mi-Kyeong Jang South Korea 17 198 0.7× 443 1.7× 366 1.5× 61 0.5× 151 1.2× 55 1.1k
L. Zhang China 9 147 0.5× 302 1.1× 259 1.1× 83 0.6× 163 1.3× 29 1.1k
Hafiz Shoaib Sarwar Pakistan 17 396 1.5× 176 0.7× 262 1.1× 54 0.4× 134 1.1× 37 935
Amal K. Hussein Egypt 16 482 1.8× 500 1.9× 386 1.6× 134 1.0× 194 1.6× 33 1.4k

Countries citing papers authored by Sandra Jesus

Since Specialization
Citations

This map shows the geographic impact of Sandra Jesus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Jesus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Jesus more than expected).

Fields of papers citing papers by Sandra Jesus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Jesus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Jesus. The network helps show where Sandra Jesus may publish in the future.

Co-authorship network of co-authors of Sandra Jesus

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Jesus. A scholar is included among the top collaborators of Sandra Jesus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Jesus. Sandra Jesus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jesus, Sandra, et al.. (2024). Optimizing insulin therapy: Are microneedles a viable alternative to subcutaneous insulin injection?. Journal of Drug Delivery Science and Technology. 101. 106229–106229. 2 indexed citations
3.
Jesus, Sandra, et al.. (2024). Exploring the immunomodulatory properties of glucan particles in human primary cells. International Journal of Pharmaceutics. 655. 123996–123996. 6 indexed citations
4.
Jesus, Sandra, et al.. (2023). Synthetic and Natural Polymeric Drug Delivery Systems - A Comprehensive Overview of Polycaprolactone and Glucan Particles. Journal of biomimetics, biomaterials and biomedical engineering. 59. 39–58. 1 indexed citations
5.
Jesus, Sandra, et al.. (2023). Endotoxin contamination of nanoparticle formulations: A concern in vaccine adjuvant mechanistic studies. Vaccine. 41(23). 3481–3485. 7 indexed citations
6.
Schmutz, Mélanie, Olga Borges, Sandra Jesus, et al.. (2020). A Methodological Safe-by-Design Approach for the Development of Nanomedicines. Frontiers in Bioengineering and Biotechnology. 8. 258–258. 49 indexed citations
7.
Jesus, Sandra, et al.. (2020). Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety. International Journal of Pharmaceutics. 589. 119776–119776. 97 indexed citations
8.
Jesus, Sandra, Ana Patrícia Marques, Edna Soares, et al.. (2020). Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility. Frontiers in Bioengineering and Biotechnology. 8. 100–100. 81 indexed citations
9.
Jesus, Sandra, et al.. (2019). Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant. Pharmaceutics. 11(2). 72–72. 32 indexed citations
10.
Jesus, Sandra, et al.. (2019). Poly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its Immunotoxicity. Frontiers in Bioengineering and Biotechnology. 7. 137–137. 41 indexed citations
11.
Jesus, Sandra, et al.. (2019). Optimization of Chitosan-α-casein Nanoparticles for Improved Gene Delivery: Characterization, Stability, and Transfection Efficiency. AAPS PharmSciTech. 20(3). 132–132. 15 indexed citations
12.
Jesus, Sandra, Mélanie Schmutz, Claudia Som, et al.. (2019). Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far. Frontiers in Bioengineering and Biotechnology. 7. 261–261. 70 indexed citations
13.
Jesus, Sandra, Edna Soares, Maria Teresa Cruz, & Olga Borges. (2018). Exosomes as adjuvants for the recombinant hepatitis B antigen: First report. European Journal of Pharmaceutics and Biopharmaceutics. 133. 1–11. 52 indexed citations
14.
Soares, Edna, Sandra Jesus, & Olga Borges. (2018). Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen. European Journal of Pharmaceutics and Biopharmaceutics. 131. 33–43. 24 indexed citations
15.
Jesus, Sandra, Elizângela H. Fragal, Adley F. Rubira, et al.. (2017). The Inclusion of Chitosan in Poly-ε-caprolactone Nanoparticles: Impact on the Delivery System Characteristics and on the Adsorbed Ovalbumin Secondary Structure. AAPS PharmSciTech. 19(1). 101–113. 15 indexed citations
16.
Soares, Edna, Sandra Jesus, & Olga Borges. (2017). Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous priming. International Journal of Pharmaceutics. 535(1-2). 261–271. 37 indexed citations
17.
Jesus, Sandra, et al.. (2016). Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles. International Journal of Pharmaceutics. 504(1-2). 59–69. 38 indexed citations
18.
19.
Lebre, Filipa, et al.. (2012). Chitosan-Based Nanoparticles as a Hepatitis B Antigen Delivery System. Methods in enzymology on CD-ROM/Methods in enzymology. 509. 127–142. 13 indexed citations
20.
Jesus, Sandra & Olga Borges. (2011). Recent Developments in the Nasal Immunization against Anthrax. 1(3). 79–91. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026